Literature DB >> 11473635

Lipoprotein-X stimulates monocyte chemoattractant protein-1 expression in mesangial cells via nuclear factor-kappa B.

E G Lynn1, Y L Siow, J Frohlich, G T Cheung, K O.   

Abstract

BACKGROUND: Lipoprotein-X (Lp-X) is an abnormal lipoprotein found in the plasma of patients with familial lecithin:cholesterol acyltransferase (LCAT) deficiency. The majority of patients with this disorder develop progressive glomerulosclerosis. One key event in the pathogenesis of glomerulosclerosis is the infiltration of monocytes into affected glomeruli. Mesangial cells can synthesize and secrete monocyte chemoattractant protein-1 (MCP-1), an important chemoattractant for monocytes. The objective of the present study was to examine the effect of Lp-X on MCP-1 expression in mesangial cells leading to an enhanced monocyte chemotaxis and to elucidate the mechanisms involved in this process.
METHODS: Lp-X was isolated from the plasma of a patient with familial LCAT deficiency. After rat mesangial cells were incubated with Lp-X for four or six hours, the expression of MCP-1 mRNA was determined by nuclease protection assay, and MCP-1 protein was measured by Western immunoblotting analysis. Monocyte chemotaxis was determined by using a Micro Chemotaxis Chamber.
RESULTS: Lp-X (50 to 100 nmol/mL) stimulated mesangial cell MCP-1 mRNA expression (137 to 220%) and MCP-1 protein levels (233 to 375%). Conditioned media collected from Lp-X-treated mesangial cells stimulated human acute monocytic leukemia (THP-1) monocyte chemotaxis (165 to 200%). The increase in MCP-1 expression in mesangial cells was associated with an elevation of intracellular diacylglycerol levels, and activation of protein kinase C (PKC) as well as nuclear factor-kappa B (NF-kappa B).
CONCLUSION: These results suggest that Lp-X participates in the pathogenesis of glomerulosclerosis and subsequent renal failure in familial LCAT deficient patients by stimulating monocyte infiltration via a mechanism involving mesangial MCP-1 expression.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11473635     DOI: 10.1046/j.1523-1755.2001.060002520.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  9 in total

1.  Advanced glycation endproduct (AGE) receptor 1 is a negative regulator of the inflammatory response to AGE in mesangial cells.

Authors:  Changyong Lu; John Cijiang He; Weijing Cai; Huixian Liu; Li Zhu; Helen Vlassara
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-02       Impact factor: 11.205

2.  Immunochemical composition of cryoglobulins generated in stroke.

Authors:  Levon Manukyan; Anna Boyajyan; Arsen Arakelyan; Violetta Ayvazyan; Elina Arakelova; Robert Sim; George Grigoryan
Journal:  J Clin Immunol       Date:  2008-11-04       Impact factor: 8.317

Review 3.  Homozygous lecithin:cholesterol acyltransferase (LCAT) deficiency due to a new loss of function mutation and review of the literature.

Authors:  Bijan Roshan; Om P Ganda; Ranil Desilva; Rose B Ganim; Edmund Ward; Sarah D Haessler; Eliana Y Polisecki; Bela F Asztalos; Ernst J Schaefer
Journal:  J Clin Lipidol       Date:  2011-08-23       Impact factor: 4.766

4.  ApoB-100-containing lipoproteins are major carriers of 3-iodothyronamine in circulation.

Authors:  Gouriprassana Roy; Ekaterina Placzek; Thomas S Scanlan
Journal:  J Biol Chem       Date:  2011-11-28       Impact factor: 5.157

5.  Corticosteroid treatment of kidney disease in a patient with familial lecithin-cholesterol acyltransferase deficiency.

Authors:  Przemysław Miarka; Barbara Idzior-Waluś; Marek Kuźniewski; Małgorzata Waluś-Miarka; Tomasz Klupa; Władysław Sułowicz
Journal:  Clin Exp Nephrol       Date:  2011-02-16       Impact factor: 2.801

6.  A novel in vivo lecithin-cholesterol acyltransferase (LCAT)-deficient mouse expressing predominantly LpX is associated with spontaneous glomerulopathy.

Authors:  Xianghong Zhu; Andrew M Herzenberg; Mohammad Eskandarian; Graham F Maguire; James W Scholey; Philip W Connelly; Dominic S Ng
Journal:  Am J Pathol       Date:  2004-10       Impact factor: 4.307

7.  Novel Missense LCAT Gene Mutation Associated with an Atypical Phenotype of Familial LCAT Deficiency in Two Portuguese Brothers.

Authors:  I Castro-Ferreira; Rute Carmo; Sérgio Estrela Silva; Otília Corrêa; Susana Fernandes; Susana Sampaio; Rodrigues-Pereira Pedro; Augusta Praça; João Paulo Oliveira
Journal:  JIMD Rep       Date:  2017-10-06

8.  Tumour necrosis factor α enhances CCL2 and ICAM-1 expression in peripheral nerve microvascular endoneurial endothelial cells.

Authors:  Kelly A Langert; Cynthia L Von Zee; Evan B Stubbs
Journal:  ASN Neuro       Date:  2013-02-06       Impact factor: 4.146

9.  Two novel mutations of lecithin:cholesterol acyltransferase (LCAT) gene and the influence of APOE genotypes on clinical manifestations.

Authors:  Akihiro Katayama; Jun Wada; Hitomi Usui Kataoka; Hiroko Yamasaki; Sanae Teshigawara; Takahiro Terami; Kentaro Inoue; Motoko Kanzaki; Kazutoshi Murakami; Atsuko Nakatsuka; Hitoshi Sugiyama; Norio Koide; Hideaki Bujo; Hirofumi Makino
Journal:  NDT Plus       Date:  2011-07-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.